30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Life Technologies Corp (LIFE)

Track

The most recent insider trading activity occurred in May 2013, with multiple sell transactions reported by executives. Notably, John A. Cottingham, Chief Legal Officer, engaged in several significant sell-offs. Other executives also made sell transactions during this period. The last recorded transaction was on May 29, 2013.
Stock chart
Ticker: LIFE Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
UPRICHARD DAVID C
1 sale — total 148,820 USD
Sale 29 May 2013
Value US$3,862,720.10 | Price 382.89 | Shares 32,023
Sale 28 May 2013
Value US$3,229,409.39 | Price 83.57 | Shares 13,172
Sale 28 May 2013
Value US$763,536.09 | Price 496.04 | Shares 53,093
Sale 28 May 2013
Value US$32,517.16 | Price 74.24 | Shares 438
Sale 24 May 2013
Value US$14,774.00 | Price 73.87 | Shares 200
Sale 24 May 2013
Value US$2,080,186.13 | Price 73.87 | Shares 28,162
Sale 24 May 2013
Value US$120,982.84 | Price 73.86 | Shares 1,638
Planned sale 11 Dec 2012
Value US$112,442.00 | Price 51.11 | Shares 2,200
Planned sale 11 Dec 2012
Value US$204,280.00 | Price 51.07 | Shares 4,000
Planned sale 11 Dec 2012
Value US$117,406.48 | Price 51.07 | Shares 2,299
Planned sale 11 Dec 2012
Value US$102,171.06 | Price 51.06 | Shares 2,001
Planned sale 11 Dec 2012
Value US$10,210.00 | Price 51.05 | Shares 200
Planned sale 11 Dec 2012
Value US$398,112.00 | Price 51.04 | Shares 7,800
Planned sale 11 Dec 2012
Value US$76,558.05 | Price 51.04 | Shares 1,500
Sale 20 Nov 2012
Value US$383,840.00 | Price 47.98 | Shares 8,000
Sale 19 Nov 2012
Value US$4,786.45 | Price 47.86 | Shares 100
Sale 19 Nov 2012
Value US$4,785.90 | Price 47.86 | Shares 100
Sale 19 Nov 2012
Value US$2,488.66 | Price 47.86 | Shares 52
Sale 19 Nov 2012
Value US$9,571.20 | Price 47.86 | Shares 200
Sale 19 Nov 2012
Value US$148,335.31 | Price 47.85 | Shares 3,100
Sale 19 Nov 2012
Value US$23,925.00 | Price 47.85 | Shares 500
Sale 6 Nov 2012
Value US$4,923.00 | Price 49.23 | Shares 100
Sale 6 Nov 2012
Value US$19,664.00 | Price 49.16 | Shares 400
Sale 6 Nov 2012
Value US$4,922.03 | Price 49.22 | Shares 100
Sale 6 Nov 2012
Value US$88,578.00 | Price 49.21 | Shares 1,800
Sale 6 Nov 2012
Value US$4,920.90 | Price 49.21 | Shares 100
Sale 6 Nov 2012
Value US$4,920.68 | Price 49.21 | Shares 100
Sale 6 Nov 2012
Value US$20,713.20 | Price 49.20 | Shares 421
Sale 6 Nov 2012
Value US$87,066.30 | Price 49.19 | Shares 1,770
Sale 6 Nov 2012
Value US$68,999.54 | Price 49.18 | Shares 1,403
Planned sale 15 Oct 2012
Value US$337,602.16 | Price 48.52 | Shares 6,958
Planned sale 1 May 2012
Value US$130,708.80 | Price 46.95 | Shares 2,784
Planned sale 1 May 2012
Value US$800,199.68 | Price 46.48 | Shares 17,216
Buy 27 Apr 2012
Value US$154,814.03 | Price 46.49 | Shares 3,330
Sale 15 Mar 2012
Value US$9,216.00 | Price 46.08 | Shares 200
Sale 9 Mar 2012
Value US$4,660.18 | Price 46.60 | Shares 100
Sale 8 Mar 2012
Value US$9,313.00 | Price 46.57 | Shares 200
Sale 27 Feb 2012
Value US$16,681.00 | Price 47.66 | Shares 350
Sale 27 Feb 2012
Value US$7,147.50 | Price 47.65 | Shares 150
Planned sale 25 Jan 2012
Value US$1,013,000.00 | Price 50.65 | Shares 20,000
Buy 22 Aug 2011
Value US$7,232.00 | Price 36.16 | Shares 200
Buy 22 Aug 2011
Value US$3,615.98 | Price 36.16 | Shares 100
Buy 22 Aug 2011
Value US$7,231.94 | Price 36.16 | Shares 200
Buy 22 Aug 2011
Value US$1,808.00 | Price 36.16 | Shares 50
Buy 22 Aug 2011
Value US$181,000.00 | Price 36.20 | Shares 5,000
Buy 5 Aug 2011
Value US$420,000.00 | Price 42.00 | Shares 10,000
Buy 1 Aug 2011
Value US$437,348.00 | Price 43.73 | Shares 10,000
Sale 7 Jun 2011
Value US$51,040.00 | Price 51.04 | Shares 1,000
Sale 3 May 2011
Value US$116,434.50 | Price 55.45 | Shares 2,100
Sale 3 May 2011
Value US$105,317.00 | Price 55.43 | Shares 1,900
Buy 2 May 2011
Value US$11,048.00 | Price 55.24 | Shares 200
Planned sale 15 Mar 2011
Value US$349,618.63 | Price 50.25 | Shares 6,958
Sale 15 Mar 2011
Value US$932,400.00 | Price 50.40 | Shares 18,500
Sale 15 Mar 2011
Value US$2,821.84 | Price 50.39 | Shares 56
Sale 11 Mar 2011
Value US$66,482.00 | Price 51.14 | Shares 1,300
Sale 11 Mar 2011
Value US$298,439.73 | Price 51.12 | Shares 5,838
Sale 11 Mar 2011
Value US$35,265.90 | Price 51.11 | Shares 690
Sale 24 Feb 2011
Value US$5,261.00 | Price 52.61 | Shares 100
Sale 18 Feb 2011
Value US$5,417.30 | Price 54.17 | Shares 100
Sale 15 Feb 2011
Value US$5,432.45 | Price 54.32 | Shares 100
Sale 11 Feb 2011
Value US$5,398.30 | Price 53.98 | Shares 100
Sale 9 Feb 2011
Value US$5,355.30 | Price 53.55 | Shares 100
Planned sale 3 Jan 2011
Value US$16,935.00 | Price 56.45 | Shares 300
Planned sale 3 Jan 2011
Value US$11,288.00 | Price 56.44 | Shares 200
Planned sale 3 Jan 2011
Value US$107,217.00 | Price 56.43 | Shares 1,900
Planned sale 3 Jan 2011
Value US$5,642.00 | Price 56.42 | Shares 100
Planned sale 3 Jan 2011
Value US$16,925.25 | Price 56.42 | Shares 300
Planned sale 3 Jan 2011
Value US$62,056.50 | Price 56.42 | Shares 1,100
Planned sale 3 Jan 2011
Value US$101,538.00 | Price 56.41 | Shares 1,800
Planned sale 3 Jan 2011
Value US$5,638.50 | Price 56.39 | Shares 100
Planned sale 3 Jan 2011
Value US$11,276.00 | Price 56.38 | Shares 200
Planned sale 3 Jan 2011
Value US$11,275.50 | Price 56.38 | Shares 200
Planned sale 3 Jan 2011
Value US$22,550.00 | Price 56.38 | Shares 400
Planned sale 3 Jan 2011
Value US$62,288.85 | Price 56.37 | Shares 1,105
Planned sale 3 Jan 2011
Value US$11,272.38 | Price 56.36 | Shares 200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-05-30 2013-05-29 S Sale UPRICHARD DAVID C Non-Executive Director
32,023 -0.8%
382.89
US$3,862,720 		32,023 -0.8% 382.89 US$3,862,720
2013-05-29 2013-05-28 S Sale COTTINGHAM JOHN A

Chief Legal Officer

Officer
13,172 +27.3%
83.57
US$3,229,409 		13,172 +27.3% 83.57 US$3,229,409
2013-05-29 2013-05-28 S Sale COTTINGHAM JOHN A

Chief Legal Officer

Officer
53,093 -16.6%
496.04
US$763,536 		53,093 -16.6% 496.04 US$763,536
2013-05-29 2013-05-28 S Sale COTTINGHAM JOHN A

Chief Legal Officer

Officer
438 -4.4%
74.24
US$32,517 		438 -4.4% 74.24 US$32,517
2013-05-29 2013-05-24 S Sale COTTINGHAM JOHN A

Chief Legal Officer

Officer
200 -2.4%
73.87
US$14,774 		200 -2.4% 73.87 US$14,774
2013-05-29 2013-05-24 S Sale COTTINGHAM JOHN A

Chief Legal Officer

Officer
28,162 -77.0%
73.87
US$2,080,186 		28,162 -77.0% 73.87 US$2,080,186
2013-05-29 2013-05-24 S Sale COTTINGHAM JOHN A

Chief Legal Officer

Officer
1,638 -16.6%
73.86
US$120,983 		1,638 -16.6% 73.86 US$120,983
2012-12-12 2012-12-11 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
2,200 -21.2%
51.11
US$112,442 		2,200 -21.2% 51.11 US$112,442
2012-12-12 2012-12-11 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
4,000 -27.8%
51.07
US$204,280 		4,000 -27.8% 51.07 US$204,280
2012-12-12 2012-12-11 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
2,299 -13.8%
51.07
US$117,406 		2,299 -13.8% 51.07 US$117,406
2012-12-12 2012-12-11 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
2,001 -10.7%
51.06
US$102,171 		2,001 -10.7% 51.06 US$102,171
2012-12-12 2012-12-11 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
200 -1.1%
51.05
US$10,210 		200 -1.1% 51.05 US$10,210
2012-12-12 2012-12-11 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
7,800 -29.2%
51.04
US$398,112 		7,800 -29.2% 51.04 US$398,112
2012-12-12 2012-12-11 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
1,500 -5.3%
51.04
US$76,558 		1,500 -5.3% 51.04 US$76,558
2012-11-21 2012-11-20 S Sale GRIMM DONALD W Non-Executive Director
8,000 -100.0%
47.98
US$383,840 		8,000 -100.0% 47.98 US$383,840
2012-11-21 2012-11-19 S Sale GRIMM DONALD W Non-Executive Director
100 -1.2%
47.86
US$4,786 		100 -1.2% 47.86 US$4,786
2012-11-21 2012-11-19 S Sale GRIMM DONALD W Non-Executive Director
100 -1.2%
47.86
US$4,786 		100 -1.2% 47.86 US$4,786
2012-11-21 2012-11-19 S Sale GRIMM DONALD W Non-Executive Director
52 -0.6%
47.86
US$2,489 		52 -0.6% 47.86 US$2,489
2012-11-21 2012-11-19 S Sale GRIMM DONALD W Non-Executive Director
200 -2.4%
47.86
US$9,571 		200 -2.4% 47.86 US$9,571
2012-11-21 2012-11-19 S Sale GRIMM DONALD W Non-Executive Director
3,100 -26.8%
47.85
US$148,335 		3,100 -26.8% 47.85 US$148,335
2012-11-21 2012-11-19 S Sale GRIMM DONALD W Non-Executive Director
500 -4.1%
47.85
US$23,925 		500 -4.1% 47.85 US$23,925
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
100 -1.8%
49.23
US$4,923 		100 -1.8% 49.23 US$4,923
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
400 -3.4%
49.16
US$19,664 		400 -3.4% 49.16 US$19,664
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
100 -1.8%
49.22
US$4,922 		100 -1.8% 49.22 US$4,922
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
1,800 -24.3%
49.21
US$88,578 		1,800 -24.3% 49.21 US$88,578
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
100 -1.3%
49.21
US$4,921 		100 -1.3% 49.21 US$4,921
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
100 -1.3%
49.21
US$4,921 		100 -1.3% 49.21 US$4,921
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
421 -5.2%
49.20
US$20,713 		421 -5.2% 49.20 US$20,713
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
1,770 -18.0%
49.19
US$87,066 		1,770 -18.0% 49.19 US$87,066
2012-11-07 2012-11-06 S Sale RICHARD KELLI

Chief Accounting Officer

Officer
1,403 -12.5%
49.18
US$69,000 		1,403 -12.5% 49.18 US$69,000
2012-10-16 2012-10-15 PlS Planned sale LEVINE ARNOLD J Non-Executive Director
6,958 -86.6%
48.52
US$337,602 		6,958 -86.6% 48.52 US$337,602
2012-05-03 2012-05-01 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
2,784 -25.3%
46.95
US$130,709 		2,784 -25.3% 46.95 US$130,709
2012-05-03 2012-05-01 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
17,216 -61.0%
46.48
US$800,200 		17,216 -61.0% 46.48 US$800,200
2012-05-01 2012-04-27 B Purchase ANDREWS RONALD ASBURY

President, Medical Sciences

Officer
3,330 +inf%
46.49
US$154,814 		3,330 +inf% 46.49 US$154,814
2012-03-16 2012-03-15 S Sale UPRICHARD DAVID C Non-Executive Director
200 -79.4%
46.08
US$9,216 		200 -79.4% 46.08 US$9,216
2012-03-12 2012-03-09 S Sale UPRICHARD DAVID C Non-Executive Director
100 -28.4%
46.60
US$4,660 		100 -28.4% 46.60 US$4,660
2012-03-09 2012-03-08 S Sale UPRICHARD DAVID C Non-Executive Director
200 -36.2%
46.57
US$9,313 		200 -36.2% 46.57 US$9,313
2012-02-28 2012-02-27 S Sale UPRICHARD DAVID C Non-Executive Director
350 -38.8%
47.66
US$16,681 		350 -38.8% 47.66 US$16,681
2012-02-28 2012-02-27 S Sale UPRICHARD DAVID C Non-Executive Director
150 -14.3%
47.65
US$7,148 		150 -14.3% 47.65 US$7,148
2012-01-26 2012-01-25 PlS Planned sale DITTAMORE RAYMOND V Non-Executive Director
20,000 -83.2%
50.65
US$1,013,000 		20,000 -83.2% 50.65 US$1,013,000
2011-08-24 2011-08-22 B Purchase Pescovitz Ora H. Non-Executive Director
200 +21.4%
36.16
US$7,232 		200 +21.4% 36.16 US$7,232
2011-08-24 2011-08-22 B Purchase Pescovitz Ora H. Non-Executive Director
100 +12.0%
36.16
US$3,616 		100 +12.0% 36.16 US$3,616
2011-08-24 2011-08-22 B Purchase Pescovitz Ora H. Non-Executive Director
200 +31.6%
36.16
US$7,232 		200 +31.6% 36.16 US$7,232
2011-08-24 2011-08-22 B Purchase Pescovitz Ora H. Non-Executive Director
50 +8.6%
36.16
US$1,808 		50 +8.6% 36.16 US$1,808
2011-08-24 2011-08-22 B Purchase Stevenson Mark

President & COO

Officer
5,000 +11.2%
36.20
US$181,000 		5,000 +11.2% 36.20 US$181,000
2011-08-05 2011-08-05 B Purchase LUCIER GREGORY T

Chief Executive Officer

Officer
10,000 +3.1%
42.00
US$420,000 		10,000 +3.1% 42.00 US$420,000
2011-08-03 2011-08-01 B Purchase MATRICARIA RONALD A Non-Executive Director
10,000 +16.7%
43.73
US$437,348 		10,000 +16.7% 43.73 US$437,348
2011-06-08 2011-06-07 S Sale UPRICHARD DAVID C Non-Executive Director
1,000 -95.1%
51.04
US$51,040 		1,000 -95.1% 51.04 US$51,040
2011-05-05 2011-05-03 S Sale UPRICHARD DAVID C Non-Executive Director
2,100 -97.6%
55.45
US$116,434 		2,100 -97.6% 55.45 US$116,434
2011-05-05 2011-05-03 S Sale UPRICHARD DAVID C Non-Executive Director
1,900 -46.9%
55.43
US$105,317 		1,900 -46.9% 55.43 US$105,317
2011-05-02 2011-05-02 B Purchase Pescovitz Ora H. Non-Executive Director
200 +inf%
55.24
US$11,048 		200 +inf% 55.24 US$11,048
2011-03-16 2011-03-15 PlS Planned sale LEVINE ARNOLD J Non-Executive Director
6,958 -86.6%
50.25
US$349,619 		6,958 -86.6% 50.25 US$349,619
2011-03-16 2011-03-15 S Sale Grossman Paul David

SVP, Corporate Strategy & Dev.

Officer
18,500 -81.2%
50.40
US$932,400 		18,500 -81.2% 50.40 US$932,400
2011-03-16 2011-03-15 S Sale Grossman Paul David

SVP, Corporate Strategy & Dev.

Officer
56 -0.2%
50.39
US$2,822 		56 -0.2% 50.39 US$2,822
2011-03-14 2011-03-11 S Sale ADAM GEORGE F JR Non-Executive Director
1,300 -32.1%
51.14
US$66,482 		1,300 -32.1% 51.14 US$66,482
2011-03-14 2011-03-11 S Sale ADAM GEORGE F JR Non-Executive Director
5,838 -59.1%
51.12
US$298,440 		5,838 -59.1% 51.12 US$298,440
2011-03-14 2011-03-11 S Sale ADAM GEORGE F JR Non-Executive Director
690 -6.5%
51.11
US$35,266 		690 -6.5% 51.11 US$35,266
2011-02-24 2011-02-24 S Sale UPRICHARD DAVID C Non-Executive Director
100 -100.0%
52.61
US$5,261 		100 -100.0% 52.61 US$5,261
2011-02-18 2011-02-18 S Sale UPRICHARD DAVID C Non-Executive Director
100 -50.0%
54.17
US$5,417 		100 -50.0% 54.17 US$5,417
2011-02-16 2011-02-15 S Sale UPRICHARD DAVID C Non-Executive Director
100 -33.3%
54.32
US$5,432 		100 -33.3% 54.32 US$5,432
2011-02-14 2011-02-11 S Sale UPRICHARD DAVID C Non-Executive Director
100 -25.0%
53.98
US$5,398 		100 -25.0% 53.98 US$5,398
2011-02-10 2011-02-09 S Sale UPRICHARD DAVID C Non-Executive Director
100 -20.0%
53.55
US$5,355 		100 -20.0% 53.55 US$5,355
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
300 -3.5%
56.45
US$16,935 		300 -3.5% 56.45 US$16,935
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
200 -2.3%
56.44
US$11,288 		200 -2.3% 56.44 US$11,288
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
1,900 -17.9%
56.43
US$107,217 		1,900 -17.9% 56.43 US$107,217
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
100 -0.9%
56.42
US$5,642 		100 -0.9% 56.42 US$5,642
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
300 -2.7%
56.42
US$16,925 		300 -2.7% 56.42 US$16,925
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
1,100 -9.1%
56.42
US$62,056 		1,100 -9.1% 56.42 US$62,056
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
1,800 -12.9%
56.41
US$101,538 		1,800 -12.9% 56.41 US$101,538
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
100 -0.7%
56.39
US$5,638 		100 -0.7% 56.39 US$5,638
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
200 -1.4%
56.38
US$11,276 		200 -1.4% 56.38 US$11,276
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
200 -1.4%
56.38
US$11,276 		200 -1.4% 56.38 US$11,276
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
400 -2.7%
56.38
US$22,550 		400 -2.7% 56.38 US$22,550
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
1,105 -6.9%
56.37
US$62,289 		1,105 -6.9% 56.37 US$62,289
2011-01-04 2011-01-03 PlS Planned sale LORIMIER BRADLEY G Non-Executive Director
200 -1.2%
56.36
US$11,272 		200 -1.2% 56.36 US$11,272
Explore more

More insider trading research around Life Technologies Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America